ÂÜÀòÂÒÂ×

Oliver Delgado has a diverse work experience spanning several prestigious institutions. Oliver began their career at Baylor College of Medicine in 1999 as a Research Coordinator III, where they worked until 2004. Following this, they joined The University of Texas Southwestern Medical Center at Dallas as a Postdoctoral Researcher II in 2010, where they stayed until 2013. Delgado then moved to MD Anderson Cancer Center, where they worked as a Postdoctoral Fellow from 2013 to 2016. Most recently, they have been employed at Resonant Therapeutics since 2018. At Resonant Therapeutics, Delgado has held various roles, including Senior Scientist in Cancer Therapeutics, Director of Research and Development, and currently, as the Executive Director of Cancer Biology since March 2022.

Oliver Delgado completed their Ph.D. in Genetics and Development; Cancer Biology at UT Southwestern Medical Center from 2004 to 2009.